Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

NCT03524326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Cutaneous Squamous Cell Carcinoma
Head and Neck Cancer
Head and Neck Carcinoma

Interventions

DRUG: Lenvatinib Pill
DRUG: Lenvatinib Pill
DRUG: Lenvatinib Pill
DRUG: Cetuximab
DRUG: Lenvatinib Pill
DRUG: Lenvatinib Pill

Sponsor

Memorial Sloan Kettering Cancer Center